Unusual Machines, Inc. disclosed that Camden Andrew Ross, President of the company, received a grant of 525,000 stock options on July 24, 2026, with an exercise price of $19.36 per share and a five-year expiration date. The options, granted under the company's 2022 Equity Incentive Plan, vest in equal quarterly installments over three years, subject to Ross's continued employment. The disclosure was filed with the SEC on July 28, 2026, and provides insight into executive compensation arrangements at the NYSE-listed company.
Key Points
- NYSE: UMAC
- President Camden Andrew Ross received 525,000 stock options granted on July 24, 2026
- Exercise price set at $19.36 per share with five-year term expiring July 24, 2031
- Options vest in equal quarterly installments over a three-year period contingent on continued employment
Executive Stock Option Grant to President of Unusual Machines
Unusual Machines, Inc. disclosed the grant of a substantial equity award to Camden Andrew Ross, who serves as President of the company. The grant consisted of 525,000 stock options with an exercise price of $19.36 per share. The transaction date for this grant was July 24, 2026, as reported in the company's official disclosure filing with the Securities and Exchange Commission. This option grant represents a standard component of executive compensation packages at publicly traded technology and manufacturing companies, aligning management incentives with shareholder value creation.
The options were granted pursuant to the company's 2022 Equity Incentive Plan, which provides the framework for equity-based compensation arrangements at Unusual Machines. The Compensation Committee of the Board of Directors approved this grant, demonstrating that the award went through the company's formal governance process. The grant also qualifies for exemption from Section 16(b) short-swing profit restrictions under Rule 16b-3, a standard exemption applied to officer and director equity grants that have been properly approved by the Compensation Committee.
Vesting Schedule and Employment Contingency
The stock options granted to President Ross feature a three-year vesting schedule with quarterly installments, a structure commonly used in executive compensation to encourage retention and performance over a multi-year period. Under the vesting terms disclosed in the filing, the options will vest in equal quarterly increments from the grant date of July 24, 2026, through July 24, 2029. Each vesting installment is contingent on Ross's continued employment with Unusual Machines or one of its subsidiaries at the applicable vesting date, creating a direct link between tenure and the realization of equity value.
This vesting arrangement is typical for executive equity awards in the public markets, as it serves multiple corporate governance objectives. The quarterly vesting approach provides regular retention incentives throughout the three-year period, while the employment contingency ensures that equity value is only realized by executives who remain with the company. The filing indicates that the vesting terms were established as part of the formal grant approval process by the Compensation Committee, confirming adherence to the company's equity incentive plan documentation and governance protocols.
Exercise Price and Five-Year Term
The stock options carry an exercise price of $19.36 per share, which represents the price at which President Ross may purchase shares of Unusual Machines common stock upon vesting and exercise of the options. The options expire on July 24, 2031, providing a five-year window from the grant date during which the options may be exercised. This five-year term is a standard timeframe for equity options granted to executives at public companies, providing sufficient duration for the executive to evaluate market conditions and decide whether to exercise.
The $19.36 exercise price establishes a reference point for determining the intrinsic value of the options at any future exercise date. If Unusual Machines stock trades above this price following vesting, the options would carry value that reflects the difference between the market price and the exercise price. Conversely, if the stock price remains below the exercise price at expiration, the options would likely expire unexercised with no value realized. The exercise price is set as of the grant date and does not adjust for future stock splits, dividends, or other capital transactions unless such adjustments are required under the plan document.
Beneficial Ownership Position Following Grant
Following the grant transaction on July 24, 2026, Camden Andrew Ross holds 525,000 stock options in derivative form, representing his right to acquire that number of shares of Unusual Machines common stock at the specified exercise price. The filing indicates that Ross holds these derivative securities directly, with no indirect beneficial ownership structure noted. Upon full vesting and exercise of all options, Ross would own 525,000 additional shares of common stock, subject to any intervening stock splits or other capital adjustments.
The disclosure format distinguishes between derivative securities, such as stock options, and the underlying common stock that would result from exercise. The filing reports that Ross beneficially owns 525,000 derivative securities following the grant, while the underlying common stock amount of 525,000 shares represents the maximum equity position that could result from full exercise of all vested options. The separation of these figures is required by SEC disclosure rules to ensure investors can clearly understand the distinction between options granted and the actual share ownership that would result upon exercise.
Governance and Compensation Committee Approval
The filing explicitly notes that the stock option grant was approved by the Compensation Committee of Unusual Machines' Board of Directors, demonstrating that the award went through the company's formal governance review process. This approval is significant from a corporate governance perspective, as it confirms that the grant was subject to independent director oversight and was not unilaterally determined by management. The Compensation Committee's involvement in approving executive equity grants is a standard practice designed to ensure fair pricing, appropriate quantity, and alignment with company performance and shareholder interests.
The exemption from Section 16(b) short-swing profit rules further confirms the grant's compliance with federal securities laws and the company's internal equity plans. Rule 16b-3 provides that certain equity awards granted with Compensation Committee approval are exempt from the prohibition on officers and directors profiting from short-term trading in company securities. This exemption streamlines the process for granting equity awards to company insiders while maintaining the protective intent of the short-swing profit rule through the requirement for Compensation Committee approval and adherence to specific procedural requirements.
2022 Equity Incentive Plan Framework
The stock options were granted under the company's 2022 Equity Incentive Plan, which serves as the primary vehicle for equity-based compensation at Unusual Machines. Equity incentive plans of this type are adopted by public companies to facilitate the grant of options, restricted stock, restricted stock units, and other equity awards to employees, officers, directors, and other service providers. The 2022 Equity Incentive Plan at Unusual Machines provides the terms and conditions governing these awards, including vesting schedules, exercise prices, and provisions regarding acceleration or forfeiture upon termination of employment.
The use of a formal equity incentive plan ensures that all equity grants comply with federal securities laws, tax regulations, and accounting standards. The plan typically includes limits on the aggregate number of shares that may be granted, specifications for setting exercise prices, and procedures for plan administration. By granting the 525,000 options pursuant to this established plan, Unusual Machines ensures that the award adheres to predetermined terms and is eligible for favorable tax treatment under Section 422 of the Internal Revenue Code, if applicable, and complies with listing standards imposed by the NYSE.
Direct Ownership Structure and Reporting Requirements
The filing reports that Camden Andrew Ross holds the stock options directly, rather than through any intermediary or indirect ownership structure such as a trust, family limited partnership, or holding company. This direct ownership classification is significant for SEC reporting purposes, as it identifies Ross as the beneficial owner of the securities in his individual capacity. The filing indicates no nature of indirect beneficial ownership, confirming that there are no additional layers of ownership structure between Ross and the options themselves.
Form 4 filings are required within two business days of any transaction in securities by officers, directors, and greater than 10 percent beneficial owners. This reporting requirement is designed to provide transparency regarding insider transactions and holdings, allowing investors and market participants to monitor the trading and compensation activity of company insiders. The filing submitted on July 28, 2026, relating to the July 24, 2026 grant date, complies with these timing requirements. Such disclosures are public information that investors may review to evaluate potential insider confidence in the company's prospects and to monitor insider holdings and transactions.
Tax and Accounting Implications for the Grant
Stock option grants to executives typically involve specific tax and accounting treatment that impacts both the company and the recipient. From the company's perspective, the grant of options under an approved equity incentive plan may result in accounting charges based on the fair value of the options as of the grant date, calculated using valuation models such as the Black-Scholes model. These charges are reflected in the company's financial statements over the vesting period and affect reported earnings. The filing does not disclose the per-option grant date fair value, which may be found in the company's proxy statement or other regulatory filings.
From the executive's perspective, the tax treatment of stock options depends on whether the options qualify as incentive stock options under Section 422 of the Internal Revenue Code or are non-qualified stock options. The filing does not specify the type of options granted. Generally, incentive stock options receive favorable tax treatment if holding period requirements are met, while non-qualified options result in ordinary income taxation upon exercise based on the spread between the exercise price and the fair market value at exercise. Executives typically consult with tax advisors to understand the tax consequences of equity awards and the optimal timing of exercise decisions.
Market Context and Investor Monitoring
The disclosure of executive compensation through Form 4 filings provides investors with real-time information regarding insider transactions and equity grants. When reviewing such disclosures, investors may consider multiple factors, including the size of the grant relative to outstanding shares and the executive's existing holdings, the exercise price relative to recent stock prices, and the vesting schedule in relation to company milestones or strategic initiatives. The grant of 525,000 options to President Ross represents a significant equity commitment by the company, and investors may monitor the subsequent vesting and exercise of these options as indicators of management confidence in company prospects.
Unusual Machines stock is traded on the New York Stock Exchange under the ticker UMAC, allowing investors to track stock price movements relative to the $19.36 exercise price of these options. The immediate share price impact of the grant disclosure was not clear from available public information. Investors monitoring executive compensation at Unusual Machines may also review proxy statements, which typically provide detailed disclosure regarding the compensation philosophy, named executive officer awards, and equity plan provisions. Such comprehensive review can provide context for understanding individual option grants and their relationship to the company's overall compensation strategy.



Please wait processing your request...